Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-04-14

AUTHORS

M. W. M. van der Poel, W. J. Mulder, G. J. Ossenkoppele, E. Maartense, M. Hoogendoorn, P. Wijermans, H. C. Schouten

ABSTRACT

Elderly patients with diffuse large B-cell lymphoma (DLBCL) are frequently not treated with standard immunochemotherapy, and this influences survival negatively. The purpose of this study was to gain more insight into treatment decision-making by hematologists. Case vignettes concerning patients with DLBCL were presented to hematologists in the Netherlands. Patient characteristics (age, comorbidity) differed per case. Respondents were asked in each case if they would treat the patient with curative intent by means of full-dose chemotherapy or chemotherapy with dose reduction or if they would not treat the patient with curative intent. The vast majority of respondents would treat an elderly patient diagnosed with DLBCL without a relevant medical history with full-dose chemotherapy irrespective of age. In the presence of comorbidity, lack of social support, cognitive disorders, and untreated depression dose reductions in advance are frequently applied or patients are not treated with curative intent. This is most pronounced for patients aged older than 80 years. Respondents working in a university hospital more frequently refrain form full-dose chemotherapy with curative intent compared to respondents working in tertiary medical teaching hospitals or general hospitals. Patients without a relevant medical history are generally treated with curative intent irrespective of age. Cognitive disorders, comorbidity, and depression reduce the change of being treated with curative intent. This is most prominent in the eldest patient category. More... »

PAGES

1373-1379

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-015-2358-3

DOI

http://dx.doi.org/10.1007/s00277-015-2358-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027500928

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25869027


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Decision Making", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Large B-Cell, Diffuse", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Physician's Role", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.412966.e", 
          "name": [
            "Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van der Poel", 
        "givenName": "M. W. M.", 
        "id": "sg:person.01077656560.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077656560.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.412966.e", 
          "name": [
            "Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mulder", 
        "givenName": "W. J.", 
        "id": "sg:person.0671450115.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671450115.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, VU University Medical Centre, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Hematology, VU University Medical Centre, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ossenkoppele", 
        "givenName": "G. J.", 
        "id": "sg:person.0632272030.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632272030.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415868.6", 
          "name": [
            "Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maartense", 
        "givenName": "E.", 
        "id": "sg:person.0671027744.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671027744.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.414846.b", 
          "name": [
            "Department of Hematology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoogendoorn", 
        "givenName": "M.", 
        "id": "sg:person.01077733174.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077733174.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Haga Hospital, The Hague, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413591.b", 
          "name": [
            "Department of Hematology, Haga Hospital, The Hague, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wijermans", 
        "givenName": "P.", 
        "id": "sg:person.010061377417.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.412966.e", 
          "name": [
            "Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schouten", 
        "givenName": "H. C.", 
        "id": "sg:person.01260716211.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260716211.96"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11764-014-0367-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027333564", 
          "https://doi.org/10.1007/s11764-014-0367-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-012-2793-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041041966", 
          "https://doi.org/10.1245/s10434-012-2793-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002770000255", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035139390", 
          "https://doi.org/10.1007/s002770000255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-010-0973-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009228562", 
          "https://doi.org/10.1007/s00432-010-0973-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11764-013-0286-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001288710", 
          "https://doi.org/10.1007/s11764-013-0286-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-012-1463-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018972979", 
          "https://doi.org/10.1007/s00277-012-1463-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-04-14", 
    "datePublishedReg": "2015-04-14", 
    "description": "Elderly patients with diffuse large B-cell lymphoma (DLBCL) are frequently not treated with standard immunochemotherapy, and this influences survival negatively. The purpose of this study was to gain more insight into treatment decision-making by hematologists. Case vignettes concerning patients with DLBCL were presented to hematologists in the Netherlands. Patient characteristics (age, comorbidity) differed per case. Respondents were asked in each case if they would treat the patient with curative intent by means of full-dose chemotherapy or chemotherapy with dose reduction or if they would not treat the patient with curative intent. The vast majority of respondents would treat an elderly patient diagnosed with DLBCL without a relevant medical history with full-dose chemotherapy irrespective of age. In the presence of comorbidity, lack of social support, cognitive disorders, and untreated depression dose reductions in advance are frequently applied or patients are not treated with curative intent. This is most pronounced for patients aged older than 80\u00a0years. Respondents working in a university hospital more frequently refrain form full-dose chemotherapy with curative intent compared to respondents working in tertiary medical teaching hospitals or general hospitals. Patients without a relevant medical history are generally treated with curative intent irrespective of age. Cognitive disorders, comorbidity, and depression reduce the change of being treated with curative intent. This is most prominent in the eldest patient category.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-015-2358-3", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "keywords": [
      "diffuse large B-cell lymphoma", 
      "full-dose chemotherapy", 
      "curative intent", 
      "relevant medical history", 
      "elderly patients", 
      "medical history", 
      "dose reduction", 
      "cognitive disorders", 
      "large B-cell lymphoma", 
      "elderly DLBCL patients", 
      "presence of comorbidities", 
      "tertiary medical teaching hospitals", 
      "B-cell lymphoma", 
      "case vignette study", 
      "Medical Teaching Hospital", 
      "standard immunochemotherapy", 
      "patient characteristics", 
      "University Hospital", 
      "DLBCL patients", 
      "General Hospital", 
      "teaching hospital", 
      "patient categories", 
      "patients", 
      "chemotherapy", 
      "influence survival", 
      "hospital", 
      "comorbidities", 
      "hematologists", 
      "social support", 
      "disorders", 
      "age", 
      "treatment", 
      "vast majority", 
      "immunochemotherapy", 
      "lymphoma", 
      "respondents", 
      "cases", 
      "intent", 
      "depression", 
      "vignette study", 
      "survival", 
      "history", 
      "study", 
      "reduction", 
      "more insight", 
      "majority", 
      "years", 
      "factors", 
      "lack", 
      "Netherlands", 
      "presence", 
      "changes", 
      "advances", 
      "purpose", 
      "categories", 
      "support", 
      "characteristics", 
      "means", 
      "insights"
    ], 
    "name": "Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study", 
    "pagination": "1373-1379", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027500928"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-015-2358-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25869027"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-015-2358-3", 
      "https://app.dimensions.ai/details/publication/pub.1027500928"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_655.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-015-2358-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2358-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2358-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2358-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-015-2358-3'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      103 URIs      89 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-015-2358-3 schema:about N042542aa6545429781742ea9f9134dc0
2 N1049e54b77a14251aa1e57f615da2668
3 N22b3c49d4a844816b6453da130b4e725
4 N46165b4b166d46b79ee53158ca4d3183
5 N5273b6a9dc474da3bcd061d8a78b0ffe
6 N61ae7930adfc426cb05d065925aa243d
7 N70db84c44a8e428d83831a9ce1d3abb2
8 N71ffc6d51e814c0a880df9d9c9aaa98f
9 N80dc852f120c4037b1df7849c0af14db
10 N9496bc39171543a48119f2df8d6d3e4e
11 Nbf84c4d324ed4a3dade850220b339385
12 Nccc3067e89be4a0e8a482a24555c47a3
13 Nec725b0467f54d9a95550ada0000b8f1
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nbd72b0f03ad04fe68c38fb93ed652cd5
17 schema:citation sg:pub.10.1007/s00277-012-1463-9
18 sg:pub.10.1007/s002770000255
19 sg:pub.10.1007/s00432-010-0973-x
20 sg:pub.10.1007/s11764-013-0286-6
21 sg:pub.10.1007/s11764-014-0367-1
22 sg:pub.10.1245/s10434-012-2793-5
23 schema:datePublished 2015-04-14
24 schema:datePublishedReg 2015-04-14
25 schema:description Elderly patients with diffuse large B-cell lymphoma (DLBCL) are frequently not treated with standard immunochemotherapy, and this influences survival negatively. The purpose of this study was to gain more insight into treatment decision-making by hematologists. Case vignettes concerning patients with DLBCL were presented to hematologists in the Netherlands. Patient characteristics (age, comorbidity) differed per case. Respondents were asked in each case if they would treat the patient with curative intent by means of full-dose chemotherapy or chemotherapy with dose reduction or if they would not treat the patient with curative intent. The vast majority of respondents would treat an elderly patient diagnosed with DLBCL without a relevant medical history with full-dose chemotherapy irrespective of age. In the presence of comorbidity, lack of social support, cognitive disorders, and untreated depression dose reductions in advance are frequently applied or patients are not treated with curative intent. This is most pronounced for patients aged older than 80 years. Respondents working in a university hospital more frequently refrain form full-dose chemotherapy with curative intent compared to respondents working in tertiary medical teaching hospitals or general hospitals. Patients without a relevant medical history are generally treated with curative intent irrespective of age. Cognitive disorders, comorbidity, and depression reduce the change of being treated with curative intent. This is most prominent in the eldest patient category.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N7b481343b1964177a1ac8952d4648584
29 N843c35b046dd4bccb4f418c97e1a7655
30 sg:journal.1358129
31 schema:keywords B-cell lymphoma
32 DLBCL patients
33 General Hospital
34 Medical Teaching Hospital
35 Netherlands
36 University Hospital
37 advances
38 age
39 case vignette study
40 cases
41 categories
42 changes
43 characteristics
44 chemotherapy
45 cognitive disorders
46 comorbidities
47 curative intent
48 depression
49 diffuse large B-cell lymphoma
50 disorders
51 dose reduction
52 elderly DLBCL patients
53 elderly patients
54 factors
55 full-dose chemotherapy
56 hematologists
57 history
58 hospital
59 immunochemotherapy
60 influence survival
61 insights
62 intent
63 lack
64 large B-cell lymphoma
65 lymphoma
66 majority
67 means
68 medical history
69 more insight
70 patient categories
71 patient characteristics
72 patients
73 presence
74 presence of comorbidities
75 purpose
76 reduction
77 relevant medical history
78 respondents
79 social support
80 standard immunochemotherapy
81 study
82 support
83 survival
84 teaching hospital
85 tertiary medical teaching hospitals
86 treatment
87 vast majority
88 vignette study
89 years
90 schema:name Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study
91 schema:pagination 1373-1379
92 schema:productId N25a0ca61acfa4c379d2309c642ef2f76
93 N3a8386deef8c4324b5be5858cdfc3f69
94 N43ee39bd2ff2469eb0c514f8db559753
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027500928
96 https://doi.org/10.1007/s00277-015-2358-3
97 schema:sdDatePublished 2022-12-01T06:33
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N00a453d352044ef0b7006cda0fbd4aba
100 schema:url https://doi.org/10.1007/s00277-015-2358-3
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N00a453d352044ef0b7006cda0fbd4aba schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 N042542aa6545429781742ea9f9134dc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Treatment Outcome
108 rdf:type schema:DefinedTerm
109 N1049e54b77a14251aa1e57f615da2668 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Decision Making
111 rdf:type schema:DefinedTerm
112 N22b3c49d4a844816b6453da130b4e725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Physician's Role
114 rdf:type schema:DefinedTerm
115 N25a0ca61acfa4c379d2309c642ef2f76 schema:name dimensions_id
116 schema:value pub.1027500928
117 rdf:type schema:PropertyValue
118 N3a8386deef8c4324b5be5858cdfc3f69 schema:name pubmed_id
119 schema:value 25869027
120 rdf:type schema:PropertyValue
121 N43ee39bd2ff2469eb0c514f8db559753 schema:name doi
122 schema:value 10.1007/s00277-015-2358-3
123 rdf:type schema:PropertyValue
124 N44b53601b7fa43bb9cf604d5d6a0acbb rdf:first sg:person.0671027744.07
125 rdf:rest Nc06f0f87835d4a09b885e398ad6d7453
126 N46165b4b166d46b79ee53158ca4d3183 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Surveys and Questionnaires
128 rdf:type schema:DefinedTerm
129 N5273b6a9dc474da3bcd061d8a78b0ffe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Female
131 rdf:type schema:DefinedTerm
132 N61ae7930adfc426cb05d065925aa243d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Middle Aged
134 rdf:type schema:DefinedTerm
135 N6e4124ea08734c2498fb70de75fab67a rdf:first sg:person.0632272030.13
136 rdf:rest N44b53601b7fa43bb9cf604d5d6a0acbb
137 N70db84c44a8e428d83831a9ce1d3abb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Aged, 80 and over
139 rdf:type schema:DefinedTerm
140 N71ffc6d51e814c0a880df9d9c9aaa98f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Lymphoma, Large B-Cell, Diffuse
142 rdf:type schema:DefinedTerm
143 N7b481343b1964177a1ac8952d4648584 schema:issueNumber 8
144 rdf:type schema:PublicationIssue
145 N80dc852f120c4037b1df7849c0af14db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Humans
147 rdf:type schema:DefinedTerm
148 N843c35b046dd4bccb4f418c97e1a7655 schema:volumeNumber 94
149 rdf:type schema:PublicationVolume
150 N9496bc39171543a48119f2df8d6d3e4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Antineoplastic Agents
152 rdf:type schema:DefinedTerm
153 Na9c4bd9639654df2a410b7fb4712fbf6 rdf:first sg:person.01260716211.96
154 rdf:rest rdf:nil
155 Nbd72b0f03ad04fe68c38fb93ed652cd5 rdf:first sg:person.01077656560.45
156 rdf:rest Nf8d6615c33154182af312a83de40674a
157 Nbf5d3f1ffe7c40caa837ca4e95d78959 rdf:first sg:person.010061377417.22
158 rdf:rest Na9c4bd9639654df2a410b7fb4712fbf6
159 Nbf84c4d324ed4a3dade850220b339385 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Male
161 rdf:type schema:DefinedTerm
162 Nc06f0f87835d4a09b885e398ad6d7453 rdf:first sg:person.01077733174.94
163 rdf:rest Nbf5d3f1ffe7c40caa837ca4e95d78959
164 Nccc3067e89be4a0e8a482a24555c47a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aged
166 rdf:type schema:DefinedTerm
167 Nec725b0467f54d9a95550ada0000b8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Age Factors
169 rdf:type schema:DefinedTerm
170 Nf8d6615c33154182af312a83de40674a rdf:first sg:person.0671450115.14
171 rdf:rest N6e4124ea08734c2498fb70de75fab67a
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
176 schema:name Oncology and Carcinogenesis
177 rdf:type schema:DefinedTerm
178 sg:journal.1358129 schema:issn 0939-5555
179 1432-0584
180 schema:name Annals of Hematology
181 schema:publisher Springer Nature
182 rdf:type schema:Periodical
183 sg:person.010061377417.22 schema:affiliation grid-institutes:grid.413591.b
184 schema:familyName Wijermans
185 schema:givenName P.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22
187 rdf:type schema:Person
188 sg:person.01077656560.45 schema:affiliation grid-institutes:grid.412966.e
189 schema:familyName van der Poel
190 schema:givenName M. W. M.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077656560.45
192 rdf:type schema:Person
193 sg:person.01077733174.94 schema:affiliation grid-institutes:grid.414846.b
194 schema:familyName Hoogendoorn
195 schema:givenName M.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077733174.94
197 rdf:type schema:Person
198 sg:person.01260716211.96 schema:affiliation grid-institutes:grid.412966.e
199 schema:familyName Schouten
200 schema:givenName H. C.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260716211.96
202 rdf:type schema:Person
203 sg:person.0632272030.13 schema:affiliation grid-institutes:grid.16872.3a
204 schema:familyName Ossenkoppele
205 schema:givenName G. J.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632272030.13
207 rdf:type schema:Person
208 sg:person.0671027744.07 schema:affiliation grid-institutes:grid.415868.6
209 schema:familyName Maartense
210 schema:givenName E.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671027744.07
212 rdf:type schema:Person
213 sg:person.0671450115.14 schema:affiliation grid-institutes:grid.412966.e
214 schema:familyName Mulder
215 schema:givenName W. J.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671450115.14
217 rdf:type schema:Person
218 sg:pub.10.1007/s00277-012-1463-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018972979
219 https://doi.org/10.1007/s00277-012-1463-9
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/s002770000255 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035139390
222 https://doi.org/10.1007/s002770000255
223 rdf:type schema:CreativeWork
224 sg:pub.10.1007/s00432-010-0973-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009228562
225 https://doi.org/10.1007/s00432-010-0973-x
226 rdf:type schema:CreativeWork
227 sg:pub.10.1007/s11764-013-0286-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001288710
228 https://doi.org/10.1007/s11764-013-0286-6
229 rdf:type schema:CreativeWork
230 sg:pub.10.1007/s11764-014-0367-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027333564
231 https://doi.org/10.1007/s11764-014-0367-1
232 rdf:type schema:CreativeWork
233 sg:pub.10.1245/s10434-012-2793-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041041966
234 https://doi.org/10.1245/s10434-012-2793-5
235 rdf:type schema:CreativeWork
236 grid-institutes:grid.16872.3a schema:alternateName Department of Hematology, VU University Medical Centre, Amsterdam, The Netherlands
237 schema:name Department of Hematology, VU University Medical Centre, Amsterdam, The Netherlands
238 rdf:type schema:Organization
239 grid-institutes:grid.412966.e schema:alternateName Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands
240 Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands
241 schema:name Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands
242 Department of Internal Medicine, Section of Hematology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands
243 rdf:type schema:Organization
244 grid-institutes:grid.413591.b schema:alternateName Department of Hematology, Haga Hospital, The Hague, The Netherlands
245 schema:name Department of Hematology, Haga Hospital, The Hague, The Netherlands
246 rdf:type schema:Organization
247 grid-institutes:grid.414846.b schema:alternateName Department of Hematology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
248 schema:name Department of Hematology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
249 rdf:type schema:Organization
250 grid-institutes:grid.415868.6 schema:alternateName Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands
251 schema:name Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...